Toxicol 1997; 37:421-450.- Dulloo AG. Ephedrine, xanthine, and prostaglandin-inhibitors: actions and interactions in the
stimulation of thermogenesis. Int J Obes (1993) 17 (suppl. 1): S35-S40. - Astrup A and Toubro S. Thermogenic, metabolic and cardiovascular responses to ephedrine
and caffeine in man. Int J Obes (1993) 17 (suppl 1): S41-S43. - Astrup A et. al. Enhanced thermogenic responsiveness during chronic ephedrine treatment in
man. Am J Clin Nutr (1985) 42: 83-94. - Breum L et. al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the
treatment of obesity. A double-blind multi-centre trial in general practice. Int J Obes
(1994) 18: 99-103. - Horton TJ and Geissler CA. Post-prandial thermogenesis with ephedrine, caffeine and aspirin
in lean, pre-disposed obese and obese women. Int J Obes (1996) 20: 91-97. - Horton TJ and Geissler CA. Aspirin potentiates the effect of ephedrine on the thermogenic
response to a meal in obese but not lean women. Int J Obes (1991) 15: 359-366. - Daly PA et. al. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human
obesity. Int J Obes (1993) 17 (suppl. 1): S73-S78. - Arner P. Adenosine, prostaglandins and phosphodiesterase as targets for obesity
pharmacotherapy. Int J Obes (1993) 17 (suppl. 1): S57-S59. - Acheson KJ et. al. Caffeine and coffee: their influence on metabolic rate and substrate
utilization in normal weight and obese individuals. Am J Clin Nutr (1980) 33: 989-997. - Astrup A et. al. Caffeine: a double-blind, placebo-controlled study of its thermogenic,
metabolic, and cardiovascular effects. Am J Clin Nutr (1990) 51: 759-767. - Weir J et. al. A high carbohydrate diet negates the metabolic effects of caffeine during
exercise. Med Sci Sports Exerc (1987) 19: 100-105. - “Fat Management! The Thermogenic Factor.” Daniel B. Mowery, PhD. Utah: Victory
Publications, 1994. - Toubro S et. al. Safety and efficacy of long-term treatment with ephedrine, caffeine and
ephedrine/caffeine mixture. Int J Obes (1993) 17 (suppl. 1) S69-S72. - Astrup A et. al. Thermogenic synergism between ephedrine and caffeine in healthy
volunteers: a double-blind, placebo-controlled study. Metabolism (1991) 40: 323-329. - Hull KM and Maher TJ. L-tyrosine potentiates the anorexia induced by mixed-acting
sympathomimetic drugs in hyperphagic rats. Journal of Pharmacology and Experimental
Therapeutics (1990) 255: 403-409. - LaFontan M et. al. Alpha-2 adrenoreceptors in lipolysis: alpha-2 antagonists and lipid
-mobilizing strategies. Am J Clin Nutr (1992) 55: 219S-227S. - Berlan M et. al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in
obese and non-obese women. Int J Obes (1991) 15: 303-315. - Galitzky, J et. al. Alpha-2 antagonist compounds and lipid mobilization: evidence for a lipid
mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest (1988)
18: 587-594. - Zahorska-Markiewicz B et. al. Adrenergic control of lipolysis and metabolic responses in
obesity. Horm Metab Res (1986) 18: 693-697. - Kucio C et. al Does yohimbine act as a slimming drug? Isr J Med Sci (1991) 27: 550-556.
- Brass EP and Hiatt WR. The role of carnitine and carnitine supplementation during exercise
in man and in individuals with special needs. J Am Coll Nutr (1998) 17: 207-215. - Decombaz J et. al. Effect of L-carnitine on submaximal exercise metabolism after depletion of
muscle glycogen. Med Sci Sports Exerc (1993) 25: 733-740.